Auxotrophic strains of Staphylococcus bacterium
AssigneeAzitra Inc
InventorRichard Andrews
Life of this patent
Estimating the term…
Abstract
The present disclosure provides recombinant Staphylococcus bacterium (e.g. S. epidermidis) that are dependent on D-alanine for growth. In one aspect, the disclosure features a recombinant Staphylococcus bacterium comprising two inactivated alanine racemase genes (Δalr1 Δalr2); and an inactivated D-alanine aminotransferase (dat) gene. In another aspect, the disclosure features a method of making the recombinant Staphylococcus bacterium. In another aspect, the disclosure features a method of treating or preventing a rash in a subject, comprising administering to the subject a population of the recombinant Staphylococcus bacterium of any one of the aspects or embodiments described herein, in an effective amount to treat or prevent the rash in the subject.
Claims9
A method of treating a rash in a subject, comprising administering to the subject a population of recombinant Staphylococcus bacterium, in an effective amount to treat the rash in the subject,
- wherein the recombinant Staphylococcus bacterium comprises two inactivated alanine racemase genes (Δalr1Δalr2);
- and an inactivated D-alanine aminotransferase (Δdat) gene,
- and wherein the Staphylococcus bacterium is Staphylococcus epidermidis (S. epidermidis), and subspecies thereof.
Dependencies are inferred from the claim text.